Sam Lazzara
Trusted Information Resource
A quick summary of some recent update activity I have noticed. Some of these have already been announced in other Cove threads.
Global
The Global Harmonization Task Force (GHTF) was replaced by the International Medical Device Regulators Forum (IMDRF). The IMDRF does not have industry representative like the GHTF did. It is comprised of regulatory authority representatives from the US, Canada, Australia, Brazil, Japan and Europe. GHTF guidance documents are now available on the IMDRF web site.
Europe
On 2013-01-24, updated harmonised standards listings were published on the Europa website. Nothing earth shattering here except EN 980 (Symbols) was removed and bizarrely EN ISO 15223-1:2012 was not added to replace it. Apparently, somebody in Europe has issues with it, so expect to see an update to the EN "informative" (aka annoying) annex before too long to enlighten us.
Europe Medical Devices Vigilance System Guidelines, MEDDEV 2.12/1 Rev 8 published January 2013 (replaces Rev 7); becomes effective July 2013.
In the attached document, I have highlighted the content that is new/revised, mostly related to In Vitro Diagnostics (IVD), In-Vitro Fertilisation (IVF) and Assisted Reproductive Technologies (ART).
Europe 2017(?) - Can you get ready by 2017 for the new European Community medical device legislation? If all proceeds as planned, the proposed medical device and IVD regulations are expected to be adopted during 2014 and would apply three and five years, respectively, after they enter into force.
EN ISO 14630:2012
Non-active surgical implants - Part 1: General requirements (ISO 14630:2012)
EN ISO 25539-2:2012
Cardiovascular implants - Endovascular devices - Part 2: Vascular stents (ISO 25539-2:2012)
ASTM Standards
ASTM F1140:2007(2012) Standard Test Methods for Internal Pressurization Failure Resistance of Unrestrained Packages
Reapproved without changes
ASTM F2063:2012 Standard Specification for Wrought Nickel-Titanium Shape Memory Alloys for Medical Devices and Surgical Implants
ASTM F640:2012 Standard Test Methods for Determining Radiopacity for Medical Use
ASTM F1929:2012 Standard Test Method for Detecting Seal Leaks in Porous Medical Packaging by Dye Penetration
US Pharmacopeia
USP Bacterial Endotoxin Test monograph update
The chapter in the USP pertaining to the Bacterial Endotoxin Test (BET) using the LAL methodology, has undergone a minor update.
The changes are:
a) The referee test is now described as the “gel-clot limit test”, rather than simply the “gel-clot test”.
b) For sample solutions, the phrases “or diluted” has been added. So that “some substances or preparations may be more appropriately dissolves or diluted.”
c) Most importantly, a note about re-validation has been added, with the phrase: “the test for interfering factors must be repeated when any condition changes that is likely to influence the result of the test.”
d) Criteria for depyrogenation has been added, with reference to USP chapter 1211.
e) A reference has been added providing more detail about the entotoxin limit calculation for general pharmaceuticals; intarthecal drugs; and radiopharmaceuticals (each of which has a different value for ‘K’ [endotoxin limit per body weight]).
f) A number of references have been added.
This change applies to USP35-NF30 (2nd supplement, page 5625). The change will be published in full in the next edition of the USP: the 36th in 2013.
Global
The Global Harmonization Task Force (GHTF) was replaced by the International Medical Device Regulators Forum (IMDRF). The IMDRF does not have industry representative like the GHTF did. It is comprised of regulatory authority representatives from the US, Canada, Australia, Brazil, Japan and Europe. GHTF guidance documents are now available on the IMDRF web site.
Europe
On 2013-01-24, updated harmonised standards listings were published on the Europa website. Nothing earth shattering here except EN 980 (Symbols) was removed and bizarrely EN ISO 15223-1:2012 was not added to replace it. Apparently, somebody in Europe has issues with it, so expect to see an update to the EN "informative" (aka annoying) annex before too long to enlighten us.
Europe Medical Devices Vigilance System Guidelines, MEDDEV 2.12/1 Rev 8 published January 2013 (replaces Rev 7); becomes effective July 2013.
In the attached document, I have highlighted the content that is new/revised, mostly related to In Vitro Diagnostics (IVD), In-Vitro Fertilisation (IVF) and Assisted Reproductive Technologies (ART).
Europe 2017(?) - Can you get ready by 2017 for the new European Community medical device legislation? If all proceeds as planned, the proposed medical device and IVD regulations are expected to be adopted during 2014 and would apply three and five years, respectively, after they enter into force.
EN ISO 14630:2012
Non-active surgical implants - Part 1: General requirements (ISO 14630:2012)
EN ISO 25539-2:2012
Cardiovascular implants - Endovascular devices - Part 2: Vascular stents (ISO 25539-2:2012)
ASTM Standards
ASTM F1140:2007(2012) Standard Test Methods for Internal Pressurization Failure Resistance of Unrestrained Packages
Reapproved without changes
ASTM F2063:2012 Standard Specification for Wrought Nickel-Titanium Shape Memory Alloys for Medical Devices and Surgical Implants
ASTM F640:2012 Standard Test Methods for Determining Radiopacity for Medical Use
ASTM F1929:2012 Standard Test Method for Detecting Seal Leaks in Porous Medical Packaging by Dye Penetration
US Pharmacopeia
USP Bacterial Endotoxin Test monograph update
The chapter in the USP pertaining to the Bacterial Endotoxin Test (BET) using the LAL methodology, has undergone a minor update.
The changes are:
a) The referee test is now described as the “gel-clot limit test”, rather than simply the “gel-clot test”.
b) For sample solutions, the phrases “or diluted” has been added. So that “some substances or preparations may be more appropriately dissolves or diluted.”
c) Most importantly, a note about re-validation has been added, with the phrase: “the test for interfering factors must be repeated when any condition changes that is likely to influence the result of the test.”
d) Criteria for depyrogenation has been added, with reference to USP chapter 1211.
e) A reference has been added providing more detail about the entotoxin limit calculation for general pharmaceuticals; intarthecal drugs; and radiopharmaceuticals (each of which has a different value for ‘K’ [endotoxin limit per body weight]).
f) A number of references have been added.
This change applies to USP35-NF30 (2nd supplement, page 5625). The change will be published in full in the next edition of the USP: the 36th in 2013.